Sunshine Biopharma (SBFM) Depreciation Expense: 2019-2025
Historic Depreciation Expense for Sunshine Biopharma (SBFM) over the last 6 years, with Sep 2025 value amounting to $95,821.
- Sunshine Biopharma's Depreciation Expense rose 48.27% to $95,821 in Q3 2025 from the same period last year, while for Sep 2025 it was $221,550, marking a year-over-year increase of 36.74%. This contributed to the annual value of $146,518 for FY2024, which is 32.35% up from last year.
- Latest data reveals that Sunshine Biopharma reported Depreciation Expense of $95,821 as of Q3 2025, which was up 32.11% from $72,533 recorded in Q2 2025.
- Sunshine Biopharma's Depreciation Expense's 5-year high stood at $95,821 during Q3 2025, with a 5-year trough of -$11,597 in Q4 2024.
- In the last 3 years, Sunshine Biopharma's Depreciation Expense had a median value of $46,744 in 2024 and averaged $45,549.
- In the last 5 years, Sunshine Biopharma's Depreciation Expense soared by 4,616.10% in 2023 and then slumped by 397.05% in 2024.
- Over the past 5 years, Sunshine Biopharma's Depreciation Expense (Quarterly) stood at $3,184 in 2021, then soared by 353.99% to $14,455 in 2022, then slumped by 72.99% to $3,904 in 2023, then slumped by 397.05% to -$11,597 in 2024, then surged by 48.27% to $95,821 in 2025.
- Its last three reported values are $95,821 in Q3 2025, $72,533 for Q2 2025, and $64,793 during Q1 2025.